Jordan Harbinger

PodcastOne is not only announcing it has signed Jordan Harbinger to a long-term deal to continue hosting his podcast with the network for the foreseeable future. It is also sending the message that it is willing to pay big money. While most publishers shy away from offering financial details about their deals, PodcastOne put in the headline of its announcement that the Harbinger renewal is valued at seven figures.

Another set of numbers explain why PodcastOne is willing to pay so much. With download numbers nearing 11 million monthly according to Podcast One and more than 300 million downloads since the show launched in 2018, The Jordan Harbinger Show is one of PodcastOne’s most listened-to series.

On the podcast, the former Wall Street attorney interviews business leaders, entertainers, scientists and athletes to an eclectic array of fascinating minds, from art forgers and arms traffickers to global spies and psychologists. Previous guests have included AirBnB's Brian Chesky, billionaire and hedge fund manager Ray Dalio, author Simon Sinek, billionaire and serial entrepreneur Mark Cuban, television journalist Anderson Cooper, Academy Award winning actor Matthew McConaughey, musician Moby, hip-hop artist T-Pain, rapper Rick Ross, scientists Neil deGrasse Tyson and Bill Nye, and athletes like Kobe Bryant, Dennis Rodman and Tony Hawk.

"Jordan embodies what podcasting is all about. His impeccable interviewing skills, his unmatched rapport with guests, his integrity and his knowledge of marketing and the business of podcasting are keystones in the growth of The Jordan Harbinger Show and his audience is ever expanding,” said PodcastOne President Kit Gray. “Not only is Jordan a dream partner in podcasting, he's also a dear friend and we are looking forward to, and anticipating, even bigger things in 2022 and beyond," he said in the announcement.

Since launching, The Jordan Harbinger Show has been named one of the "Best Of" and "Most Downloaded Shows" by Apple and has been on the iTunes Top 50 Chart in the U.S., Canada, UK and Australia.